TG-100435
TG-100435 is a multitargeted, orally active protein tyrosine kinase inhibitor, with Ki of 13 to 64 nM for Src, Lyn, Abl, Yes, Lck, and EphB4. TG-100435 plays an important role in cancer research[1].
Product Specifications
CAS Number
867330-68-5
UNSPSC
12352005
Target
Bcr-Abl; Ephrin Receptor; Src
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
ClC1=C(C2=CC3=C(C(C)=C2)N=C(NC4=CC=C(C=C4)OCCN5CCCC5)N=N3)C(Cl)=CC=C1
Molecular Formula
C26H25Cl2N5O
Molecular Weight
494.42
References & Citations
[1]Steven X Hu, et al. Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7- (2,6-dichloro-phenyl) -5-methyl-benzo[1,2,4]triazin-3-yl]-[4- (2-pyrrolidin-1-yl-ethoxy) -phenyl]-amine) and its active N-oxide metabolite TG100855 ([7- (2,6-dichloro-phenyl) -5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2- (1-oxy-pyrrolidin-1-yl) -ethoxy]-phenyl}-amine) . Comparative Study Drug Metab Dispos. 2007 Jun;35 (6) :929-36.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV697453 1.0 µg DNA
PBXIP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details bs-3939R-PE-Cy5-01 20 µL
GNAS Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details